News

“We are very pleased to have ELITech UK become our exclusive UK distributor. Their demonstrated expertise in this market and knowledge of our customer base in the UK

Excluding a 10% currency impact, first quarter sales grew organically by 1% from a year ago. Organic sales for the Company’s Research business grew over 3%, with individual

NanoBio, a biopharmaceutical company, has reported that the FDA has approved the company’s investigational new drug application for the Phase I clinical study of NB-1008, a seasonal influenza

Pharmasset, a clinical-stage pharmaceutical company, has reported that after a discussion with its independent data safety monitoring board and the FDA, the company has decided to voluntarily terminate

Non-GAAP net income grew 10% to $288.1 million, or $1.04 per diluted share, compared with $260.9 million, or $0.95 per diluted share, in the same period last year.

GlaxoSmithKline, or GSK, and Stiefel Laboratories have signed an agreement to create a new specialist dermatology business. Under the terms of the agreement GSK will acquire the total

Medarex, a biopharmaceutical company, has reported encouraging preliminary data from an ongoing Phase I clinical trial of MDX-1401 in patients with relapsed or refractory Hodgkin’s lymphoma that demonstrated

Merck Serono, a division of German drug maker Merck KGaA, has launched Kuvan, an oral therapeutic indicated for the treatment of hyperphenylalaninaemia due to phenylketonuria or tetrahydrobiopterin deficiency,

Impax Pharmaceuticals, the brand products division of Impax Laboratories, has started a Phase III trial of IPX066 in Parkinson’s disease or PD patients based on encouraging interim data